Schedule 13G ownership disclosure
Flex Pharma, Inc.
Security class unavailable · CUSIP: 33938A105
Event date: 2018-07-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,132,987
- Percent of class
- 6.2900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-18-050116
- Form type
- SC 13G
- Filer
- Salarius Pharmaceuticals, Inc.
- CIK
- CIK 1615219
- Filed
- Aug 07, 2018
- Reporting period
- Jul 31, 2018
- Description
- Schedule 13G beneficial ownership